
Dr. Ahmed Mohamoud Baker
Cancer Immunotherapy Assistant Professor - College of Applied Medical Sciences Vice Dean of Scientific Research for Technical Affairs and Development Clinical Laboratory Science Department
Summary
My long-term research interests focus on the development and improvement of immunotherapeutic strategies, including oncolytic viruses, gene therapy, cancer vaccine, and immune checkpoint inhibitors, for the treatment of several cancers and infectious diseases.
Experience
- Vice-dean for central laboratories support at the Deanship of Scientific Research, Taibah University, Madinah, Saudi Arabia. (2020–present)
- Director of the Science and Technology Unit at Taibah University. (2019 – 2020)
- Director of The Center of Nanotechnology at Taibah University. (2019 – Present)
- Assistant to the Vice Dean for Graduate Studies and Scientific Research, College of Applied Medical Sciences, Taibah University, (2019 – 2020)
- Assistant to the Head of Department of Medical Sciences, College of Applied Medical Sciences, Taibah University, (2019 – 2020)
- Adjunct associate scientist, Immunology Research Program, KIMARC, KSA 2019-present.
- Harvard Medical School Faculty Member (part-time lecturer), Boston, MA, USA. (2018 – 2019)
- Assistant professor, Taibah University, (2018 – Present)
- Brigham and Women’s Hospital Research Fellow in Neurosurgery department, Boston, MA, USA (2017 – 2018).
- Senior Laboratory Technician, Royal Commission Hospital, Jubail Industrial City, (2006 – 2007)
- Publications: ~ 25, in prestigious journals including recent publications in Cell, Nature Communications, and Science Advances.
Education
- Harvard Medical School Postdoctoral Fellowship, Immunotherapy and Oncolytic Virotherapy (2017 – 2018)
- University of Ottawa Doctor of Philosophy (Ph.D.), Medical Microbiology and Immunology (2012 – 2016)
- University of Ottawa Master’s degree, Medical Microbiology and Immunology (2010 – 2012)
My long-term research interests focus on the development and improvement of immunotherapeutic strategies, including oncolytic viruses, gene therapy, cancer vaccine, and immune checkpoint inhibitors, for the treatment of several cancers and infectious diseases.